Meghana V Trivedi (Meghana Trivedi)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Venues

Research square

The Annals of pharmacotherapy

Molecular cancer research : MCR

International journal of clinical pharmacy

University of Houston

University of Houston (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Houston

United States

Assistant Professor :: PPTR

Education History

University of Houston

United States

PHD

Publications

Prajakta P Masurkar, Haluk Damgacioglu, Ashish A Deshmukh, Meghana V Trivedi
Cost Effectiveness of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2- Metastatic Breast Cancer in Postmenopausal Women in the USA. PharmacoEconomics (2023)
Sama Rahimi, Onyebuchi Ononogbu, Anjana Mohan, Daniel Moussa, Susan Abughosh, Meghana V Trivedi
Adherence to oral endocrine therapy in racial/ethnic minority patients with low socioeconomic status before and during the COVID-19 pandemic. International journal of clinical pharmacy (2023)
Sama Rahimi, Onyebuchi Ononogbu, Anjana Mohan, Daniel Moussa, Susan Abughosh, Meghana V Trivedi
Identifying the predictors of adherence to oral endocrine therapy in racial/ethnic minority patients with low socioeconomic status. Research square (2022)
Sama Rahimi, Onyebuchi Ononogbu, Anjana Mohan, Daniel Moussa, Susan Abughosh, Meghana V Trivedi
Identifying the predictors of adherence to oral endocrine therapy in racial/ethnic minority patients with low socioeconomic status. Research square (2022)
Rutugandha Paranjpe, Dima Basatneh, Gabriel Tao, Carmine De Angelis, Sobia Noormohammed, Ekim Ekinci, Susan Abughosh, Romi Ghose, Meghana V Trivedi
Neratinib in HER2-Positive Breast Cancer Patients. The Annals of pharmacotherapy 53 (6) (2019)
Arturo B Ramirez, Raksha Bhat, Debashish Sahay, Carmine De Angelis, Hariprasad Thangavel, Sina Hedayatpour, Lacey E Dobrolecki, Agostina Nardone, Mario Giuliano, Chandandeep Nagi, Mothaffar Rimawi, C Kent Osborne, Michael T Lewis, Jackie L Stilwell, Eric P Kaldjian, Rachel Schiff, Meghana V Trivedi
Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and analysis. BMC cancer 19 (1) (2019)
Johnny M Hoang, Navneet Upadhyay, Dozie N Dike, Jaekyu Lee, Michael L Johnson, Charles S Cleeland, Tito Mendoza, Hua Chen, Meghana V Trivedi
Patient-reported outcomes in light of supportive medications in treatment-naïve lung cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 28 (4) (2019)
Carmine De Angelis, Chandandeep Nagi, Cliff C Hoyt, Linying Liu, Kristin Roman, Nicholas Wang, Yi Zheng, Jamunarani Veeraraghavan, Vidyalakshmi Sethunath, Paolo G Nuciforo, Anna Tsimelzon, Sufeng Mao, Susan G Hilsenbeck, Meghana V Trivedi, Maria Letizia Cataldo, Anne Pavlick, Antonio C Wolff, Britta Weigelt, Jorge S Reis-Filho, Aleix Prat, Carolina Gutierrez, Charles Kent Osborne, Mothaffar F Rimawi, Rachel Schiff
Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (3) (2019)
Micaela Montanari, Maria Rita Carbone, Luigi Coppola, Mario Giuliano, Grazia Arpino, Rossella Lauria, Agostina Nardone, Felicia Leccia, Meghana V Trivedi, Corrado Garbi, Roberto Bianco, Enrico V Avvedimento, Sabino De Placido, Bianca Maria Veneziani
Epigenetic Silencing of THY1 Tracks the Acquisition of the Notch1-EGFR Signaling in a Xenograft Model of CD44+/CD24low/CD90+ Myoepithelial Cells. Molecular cancer research : MCR 17 (2) (2018)
Raksha R Bhat, Puja Yadav, Debashish Sahay, Dharmendra K Bhargava, Chad J Creighton, Sahar Yazdanfard, Ahmed Al-Rawi, Vikas Yadav, Lanfang Qin, Sarmistha Nanda, Vidyalakshmi Sethunath, Xiaoyong Fu, Carmine De Angelis, Vihang A Narkar, C Kent Osborne, Rachel Schiff, Meghana V Trivedi
GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer. Breast cancer research and treatment 170 (2) (2018)
Kaitlin Rascon, Goran Flajc, Carmine De Angelis, Xinli Liu, Meghana V Trivedi, Ekim Ekinci
Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients. The Annals of pharmacotherapy 53 (5) (2018)

Meghana V Trivedi.css-eqlu8i{font-size:small;padding-left:4px;} (Meghana Trivedi)

Publication Activity (10 Years)

Top Topics

Top Venues

Meghana V Trivedi (Meghana Trivedi)